Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zepp Health (ZEPP) Other Non-Current Assets (2017 - 2025)

Historic Other Non-Current Assets for Zepp Health (ZEPP) over the last 9 years, with Q3 2025 value amounting to $4.9 billion.

  • Zepp Health's Other Non-Current Assets fell 3306.29% to $4.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 billion, marking a year-over-year decrease of 3306.29%. This contributed to the annual value of $4.6 billion for FY2024, which is 4740464.01% up from last year.
  • Zepp Health's Other Non-Current Assets amounted to $4.9 billion in Q3 2025, which was down 3306.29% from $4.7 billion recorded in Q2 2025.
  • Zepp Health's 5-year Other Non-Current Assets high stood at $10.1 billion for Q3 2023, and its period low was $3.0 million during Q1 2021.
  • For the 5-year period, Zepp Health's Other Non-Current Assets averaged around $4.4 billion, with its median value being $4.4 billion (2025).
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first tumbled by 8952.29% in 2021, then soared by 10904816.04% in 2022.
  • Zepp Health's Other Non-Current Assets (Quarter) stood at $3.1 million in 2021, then soared by 131.19% to $7.1 million in 2022, then skyrocketed by 34.97% to $9.6 million in 2023, then skyrocketed by 48076.89% to $4.6 billion in 2024, then grew by 5.64% to $4.9 billion in 2025.
  • Its last three reported values are $4.9 billion in Q3 2025, $4.7 billion for Q2 2025, and $4.4 billion during Q1 2025.